Skip to main content
ConductScienceScienceDex

Daniela Annenelie Bota

NIH Rank #11880
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10115491Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Neurology
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#11,880
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Daniela Annenelie Bota. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Daniela Annenelie Bota as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA263806-04R01
    Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    University of California-Irvine
    $574.8K
    award amount
  • 5R01NS109423-05R01
    Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
    University of California-Irvine
    $399.3K
    award amount
  • 3R01CA263806-04S2R01
    Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    University of California-Irvine
    $95.5K
    award amount
  • 3R01CA263806-04S1R01
    Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    University of California-Irvine
    $82.5K
    award amount
  • 3R01CA263806-03S1R01
    Supplement to Promote Diversity: Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    University of California-Irvine
    $33.1K
    award amount
  • 3R01CA263806-03S2R01
    Supplement to Promote Diversity:Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    University of California-Irvine
    $18.3K
    award amount
  • 3R01NS109423-05S1R01
    Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
    University of California-Irvine
    $9.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Daniela Annenelie Bota as a PI.

FY2024 award administered by University of California-Irvine (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California-Irvine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Daniela Annenelie Bota.

Kalpna Gupta
University of California-Irvine
8
shared awards
Bhaskar Chandra Das
University of California-Irvine
2
shared awards

Explore further

Find collaborators for Daniela Annenelie Bota

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →